Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04437706 · ClinicalTrials.gov registry record
Network-Targeted Strategies for Efficient Community SARS-CoV-2 (COVID-19) Sampling
A clinical trial of COVID-19 and SARS-CoV-2, sponsored by Duke University.
- Completed
- Registry status
- 602
- Enrollment target
- 1
- Study location
NCT04437706 is a study of COVID-19 and SARS-CoV-2 that has completed, run by Duke University. The registered enrollment target is 602 participants, below the 55,212-participant average among 203 other COVID-19 trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04437706, a study of COVID-19 and SARS-CoV-2, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 602 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective is to use "network targeted sampling design" to detect active and/or undiagnosed cases of COVID-19 in the community and determine the spread or distribution of 1) active infection, and 2) past exposure. The hypothesis is that there are many undiagnosed and/or asymptomatic people in the community who may be unknowingly spreading the virus or have been exposed and have antibodies. We propose to implement respondent-driven sampling (RDS) which leverages effort on the part of seed or index cases to recruit contacts for participation.
Conditions Studied
Study Locations (1)
North Carolina
- Margaret Pendzich - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 602 participants |
| Start Date | 2020-12-11 |
| Est. Completion | 2022-07-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04437706
The ClinicalTrials.gov registry entry for NCT04437706 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 602 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55,212-participant average among 203 other COVID-19 trials with a reported enrollment target (99% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with COVID-19 appearing as the primary indexed condition, and to 0 interventions.
NCT04437706 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT04437706 about?
NCT04437706 is a clinical study titled "Network-Targeted Strategies for Efficient Community SARS-CoV-2 (COVID-19) Sampling". The primary objective is to use "network targeted sampling design" to detect active and/or undiagnosed cases of COVID-19 in the community and determine the spread or distribution of 1) active infection, and 2) past exposure. The hypothesis is that there are many undiagnosed and/or asymptomatic peopl...
What is the current status of trial NCT04437706?
This trial is currently completed. The enrollment target is 602 participants. The study started on 2020-12-11. Estimated completion is 2022-07-25.
What conditions does trial NCT04437706 study?
This clinical trial studies the following conditions: COVID-19, SARS-CoV-2.
Who is sponsoring clinical trial NCT04437706?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04437706 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Arginine Replacement Therapy in COVID-19
RECRUITING · Phase 2
-
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
RECRUITING · Phase 2
-
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
RECRUITING
-
COVID-19 Health Adjustments in Nutrition, General Wellness, and Exercise
RECRUITING
-
The Impact of COVID-19 on Maternal and Neonatal Outcomes
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.